What are D (delta) cells?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Delta (D) Cells in the Pancreas

Delta cells are specialized endocrine cells in the pancreatic islets that secrete somatostatin, which acts as a paracrine inhibitor of insulin, glucagon, and somatostatin secretion, playing a crucial role in regulating glucose homeostasis. 1

Characteristics and Morphology

  • Delta cells comprise approximately 5% of the cells in pancreatic islets but have complex morphology allowing them to establish extensive communication networks throughout the islet despite their scarcity 1, 2
  • Delta cells are predominantly located in close proximity to capillaries (84%), with their immunoreactive material accumulated in cell parts facing the capillaries or perivascular spaces 3
  • About 67% of delta cells tend to be arranged in contiguity to other delta cells, forming interconnected networks 3
  • Delta cells have a distinctive morphology that allows them to interact with many more islet cells than their low numbers might suggest 1

Physiological Function

  • Delta cells contain ATP-sensitive potassium channels (KATP channels) that close when glucose levels are elevated, initiating membrane depolarization and electrical activity that increases somatostatin secretion 1
  • Somatostatin secreted by delta cells acts locally within the islets as a paracrine or autocrine inhibitor of insulin, glucagon, and somatostatin secretion 1, 2
  • The inhibitory effects of somatostatin are mediated through activation of somatostatin receptors coupled to inhibitory G proteins, which suppress electrical activity and exocytosis in alpha and beta cells 1
  • Factors released by neighboring alpha or beta cells can amplify glucose-induced effects on somatostatin secretion from delta cells, creating a feedback loop 1, 4

Cellular Connections and Communication

  • Delta cells are electrically coupled to beta cells via gap junctions, suggesting they function as more than just paracrine inhibitors 2
  • This gap junction communication between delta cells and beta cells creates a negative feedback loop that helps determine and stabilize the blood glucose set point 4
  • Somatostatin released from delta cells reaches other islet cells mainly via the intrainsular circulation or along the perivascular space 3

Role in Disease States

  • Somatostatin secretion is perturbed in animal models of diabetes mellitus, which may explain the loss of appropriate hypoglycemia-induced glucagon secretion 1
  • This defect in glucagon secretion could potentially be mitigated by somatostatin receptor 2 antagonists 1
  • The discovery of gap junction communication between delta cells and beta cells provides new insights into the contribution of delta cells to islet hormonal defects observed in both type 1 and type 2 diabetes 2
  • Somatostatin antagonists or agents that suppress somatostatin secretion have been proposed as an adjunct to insulin therapy in diabetes treatment 1

Delta Cells in Other Tissues

  • Delta cells are not exclusive to the pancreas; they have also been identified in the gastrointestinal tract, including the human colon and rectum 5
  • In the digestive tract, these cells are fairly argyrophil (silver-staining) and correspond to somatostatin-immunoreactive cells 5
  • The distribution and function of delta cells may vary between different tissues and organs 5

Human Translational Note: Understanding delta cell function has important clinical implications for diabetes management, as targeting somatostatin signaling could potentially improve glycemic control in patients with diabetes.

Human Translational Note: Understanding delta cell function has important clinical implications for diabetes management, as targeting somatostatin signaling could potentially improve glycemic control in patients with diabetes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.